Table 3.
Matrix for determining the requirement level and acceptable end points for health effects.
| Categorization regarding “target group” | Categorization regarding “function” | ||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| 4 Diagnosis | |||||||||||
| 8 Direct intervention | |||||||||||
| 6 Complex monitoring | 7 Indirect intervention | 5 Simple monitoring | |||||||||
| 4 Highly vulnerable and/or unstable health status | High |
|
High |
|
High |
|
|||||
| 2 acutely ill, not life-threatening/ 3 chronically stable | High | Medium | Medium | ||||||||
| 1 healthy with risk factors | High |
|
|
Medium |
|
|
|
Low |
|
|
|
|
|
|
|
|
|
|
|
|
||||
| Acceptable endpoints for health care effects |
Patient-relevant benefit |
Efficacy (surrogate parameters if applicable) |
other intermediate outcomes, e.g. adherence |
||||||||